Table 3.
Patient No. | Anti-platelet protocol | Device and associated intracranial technique | TICI | Postoperative hemorrhage | Stent used | mRS at 3 months | Follow-up arteriogram at 6 months Stent patency | Follow-up arteriogram at 6 months Stent displacement |
---|---|---|---|---|---|---|---|---|
1 | 1 g of LAS IV + 300 mg Clopidogrel PO | SOLITAIRE | 2B | NO | Wingspan 4.5 × 20 mm Wingspan 4.5 × 20 mm | 0 | YES | YES |
2 | 1 g of LAS IV + Abciximab | SOLITAIRE | 3 | NO | Wingspan 4.5 × 20 mm | 0 | YES | NO |
3 | 1 g of LAS IV | - | 3 | NO | Wingspan 4.5 × 20 mm Wingspan 4 × 20 mm Wallstent 5 × 30 mm | 3 | YES | YES |
4 | 1 g of LAS IV + 300 mg Clopidogrel PO | SOLITAIRE | 3 | NO | Wingspan 4.5 × 25 mm Wingspan 4 × 20 mm Wallstent 5 × 30 Wallstent 7 × 30 | 0 | YES | YES |
5 | 1 g of LAS IV + Tirofiban | SOLITAIRE | 3 | NO | Wingspan 4.5 × 20 mm Wingspan 4.5 × 15 mm | 2 | YES | NO |
6 | 1 g of LAS IV + 300 mg Clopidogrel PO | SOLITAIRE | 2B | NO | Wingspan 4.5 × 25 mm Wingspan 4.5 × 20 mm | 1 | YES | NO |
7 | 1 g of LAS IV + 300 mg Clopidogrel PO | - | 3 | NO | Wingspan 4.5 × 25 mm Wallstent 5 × 30 mm | 1 | YES | YES |
8 | 1 g of LAS IV + Tirofiban | SOLITAIRE | 3 | NO | Wingspan 4.5 × 25 mm Wingspan 4.5 × 25 mm | 1 | YES | NO |
9 | 1 g of LAS IV + Tirofiban | - | 3 | NO | Wingspan 4.5 × 25 mm | 0 | YES | NO |
10 | 1 g of LAS IV + Tirofiban | - | 3 | NO | Wingspan 4.5 × 20 mm Wingspan 4.5 × 15 mm Wallstent 5 × 30 mm | 0 | YES | YES |
11 | 1 g of LAS IV | SOLITAIRE | 2B | NO | Wingspan 4.5 × 20 mm | 0 | YES | NO |
IV: intravenous; LAS: lysine acetylsalicylate; mos: months; mRS: modified Rankin Scale; PO: by mouth